BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Cheap Stocks to Buy for High Returns in 2026. On March 12, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) released positive data from ongoing trials of VOXZOGO, which is the company’s approved treatment for achondroplasia. ​Achondroplasia is a genetic condition that causes dwarfism and stunted growth in children. The recent data reported by the company suggests that starting treatment before the age of 2 years maximizes benefits, including height gains, ...